By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Factor Xa inhibitors > Savaysa > Savaysa Side Effects
Factor Xa inhibitors

Savaysa Side Effects

Note: This document contains side effect information about edoxaban. Some dosage forms listed on this page may not apply to the brand name Savaysa.

Summary

More frequent side effects include: hemorrhage. Continue reading for a comprehensive list of adverse effects.

Applies to edoxaban: oral tablet.

Warning

Oral route (Tablet)

Reduced Efficacy in Nonvalvular Atrial Fibrillation Patients with a Creatinine Clearance (CrCl) Greater than 95 mL/minute; Premature Discontinuation of Edoxaban Increases the Risk of Ischemic Events; Spinal/Epidural HematomaReduced Efficacy in Nonvalvular Atrial Fibrillation Patients with CrCl greater than 95 mL/min: Edoxaban should not be used in patients with CrCl greater than 95 mL/min. In the ENGAGE AF-TIMI 48 study, nonvalvular atrial fibrillation patients with CrCl greater than 95 mL/min had an increased rate of ischemic stroke with edoxaban 60 mg once daily compared to patients treated with warfarin. In these patients another anticoagulant should be used.Premature Discontinuation of Edoxaban Increases the Risk of Ischemic Events: Premature discontinuation of any oral anticoagulant in the absence of adequate alternative anticoagulation increases the risk of ischemic events. If edoxaban is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant as described in the transition guidance.Spinal/Epidural Hematoma: Epidural or spinal hematomas may occur in patients treated with edoxaban who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures.

Serious side effects of Savaysa

Along with its needed effects, edoxaban (the active ingredient contained in Savaysa) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking edoxaban:

More common

  • Bloody nose
  • heavy non-menstrual vaginal bleeding
  • pale skin
  • troubled breathing with exertion
  • unusual bleeding or bruising
  • unusual tiredness or weakness

Less common

  • Bloody or black, tarry stools
  • vomiting of blood or material that looks like coffee grounds

Rare

  • Confusion
  • cough
  • difficulty with speaking
  • double vision
  • fever
  • headache, sudden, severe
  • inability to move the arms, legs, or facial muscles
  • inability to speak
  • nausea
  • slow speech
  • vomiting

Incidence not known

  • Back pain
  • bleeding gums
  • blood in urine
  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • fast heartbeat
  • hives, itching, rash, redness of the skin
  • hoarseness
  • irritation
  • joint pain, stiffness or swelling
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, sex organs
  • leg weakness
  • loss of bladder or bowel control
  • paralysis
  • pinpoint red spots on the skin
  • stomach pain
  • swelling of the eyelids, face, lips, hands, or feet
  • tightness in the chest
  • troubled breathing or swallowing

Other side effects of Savaysa

Some side effects of edoxaban may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

  • Dizziness

For Healthcare Professionals

Applies to edoxaban: oral tablet.

General

During nonvalvular atrial fibrillation treatment, the most common adverse reactions were bleeding and anemia. During deep venous thromboembolism and pulmonary embolism treatment, the most common adverse reactions were bleeding, rash, abnormal liver function tests, and anemia.[Ref]

Hematologic

Very common (10% or more): Any bleeding (21.7%), clinically-relevant non-major bleeding (up to 18.1%)

Common (1% to 10%): Major bleeding, anemia-related adverse events, non-fatal non-critical organ bleeding, clinically relevant bleeding, anemia

Uncommon (0.1% to 1%): Fatal bleeding, non-fatal critical organ bleeding, a 2 g/dL or greater decrease in hemoglobin, blood loss requiring transfusion of 2 or more units of RBC, thrombocytopenia

Rare (less than 0.1%): Fatal non-intracranial bleeding[Ref]

Major bleeding included intracranial hemorrhage (ICH), gastrointestinal hemorrhage, and fatal bleeds. A major bleeding event was defined as clinically overt bleeding that met one of the following criteria: fatal bleeding, symptomatic bleeding in a critical site (e.g. spine, eye), drop in hemoglobin of at least 2 g/dL, or a drop in hematocrit of at least 6%. A clinically relevant non-major bleed was defined as overt bleeding that required medical intervention.[Ref]

Gastrointestinal

Major GI bleeds included both upper and lower GI bleeds. A GUSTO severe GI bleed is defined as a severe or life-threatening bleed that causes hemodynamic compromise and requires intervention.[Ref]

Common (1% to 10%): Major gastrointestinal (GI) bleeding, upper GI bleeding, lower GI bleeding (including anorectal bleeding), oral and pharyngeal bleeding, abdominal pain, nausea

Uncommon (0.1% to 1%): GUSTO severe GI bleeding

Rare (less than 0.1%): Fatal GI bleed, retroperitoneal hemorrhage[Ref]

Nervous system

Common (1% to 10%): Dizziness, headache

Uncommon (0.1% to 1%): Any intracranial hemorrhage (ICH), hemorrhagic stroke, ICH other than hemorrhagic stroke, fatal ICH[Ref]

ICH included hemorrhagic stroke, subarachnoid hemorrhage, epidural/subdural hemorrhage, and ischemic stroke with major hemorrhage.[Ref]

Genitourinary

Common (1% to 10%): Vaginal bleeding, macroscopic hematuria, urethral bleeding[Ref]

Dermatologic

Common (1% to 10%): Cutaneous soft tissue bleeding, rash, pruritus

Uncommon (0.1% to 1%): Urticaria[Ref]

Hepatic

Common (1% to 10%): Abnormal liver function tests, blood bilirubin increased, gamma-glutamyltransferase increased

Uncommon (0.1% to 1%): Blood alkaline phosphatase increased, transaminases increased[Ref]

Respiratory

Common (1% to 10%): Epistaxis

Uncommon (0.1% to 1%): Interstitial lung disease (ILD), hemoptysis[Ref]

Most cases of ILD were confounded by concurrent amiodarone, which is known to cause ILD, or infectious pneumonia. Overall, 5 patients out of 5417 died of ILD during the course of the study.[Ref]

Other

Common (1% to 10%): Puncture site bleeding

Uncommon (0.1% to 1%): Surgical site hemorrhage

Rare (less than 0.1%): Procedural hemorrhage[Ref]

Immunologic

Uncommon (0.1% to 1%): Hypersensitivity

Rare (less than 0.1%): Anaphylactic reaction, allergic edema[Ref]

Ocular

Uncommon (0.1% to 1%): Conjunctival/scleral hemorrhage, intraocular hemorrhage[Ref]

Musculoskeletal

Rare (less than 0.1%): Intramuscular hemorrhage (no compartment syndrome), intra-articular hemorrhage

Frequency not reported: Compartment syndrome[Ref]

Cardiovascular

Rare (less than 0.1%): Pericardial hemorrhage

Frequency not reported: Hypoperfusion[Ref]

Renal

Frequency not reported: Renal failure[Ref]

Share this Article
Latest News
Medical News

Seed oils: Omega-6 fatty acids may lower diabetes, heart disease risk

Jun 01, 2025
Type 2 diabetes: Sugary drinks may significantly raise risk
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by